BusinessEarth Science Tech Inc. Signs Contract with CDBQ to Advance Phase-2 Rollout on it’s CBD PatentsBy Nasdaq OMXAug 1, 2017, 12:25 PM UTC
BusinessEmployee Language Proficiency Helps Global Businesses Compete, Says New Joint Study by Forbes Insights and Rosetta StoneBy Nasdaq OMXMar 30, 2017, 12:15 PM UTC
BusinessETST Announces 60-Patient Clinical Prelaunch Study for its MSN-2 Medical Device for the Diagnosis of Chlamydia & Gonorrhea, ETST Elects Dr. Michel Aubé as New CEO & CSO, and Nickolas Tabraue as President.By Nasdaq OMXNov 21, 2016, 1:15 PM UTC
BusinessPrimary Endpoint Met in pSivida’s Utilization Study of New Medidur™ Inserter with Smaller Diameter NeedleBy Nasdaq OMXAug 9, 2016, 2:00 PM UTC
BusinessAgile Therapeutics to Present at Women’s Health 2016: The 24th Annual CongressBy Nasdaq OMXApr 15, 2016, 12:00 PM UTC
BusinessEarth Science Tech, Inc Announces Positive Results from First Pre-Clinical Study on New Hampshire Participate #1 of Dysfunctional Veterans with PTSD (Posttraumatic Stress Disorder) using ETST High Grade Hemp CBD (Cannabidiol)By Nasdaq OMXApr 11, 2016, 2:06 PM UTC
BusinessMoney Under 35: How young adults are faring financially in today's economyBy Nasdaq OMXDec 9, 2015, 1:00 PM UTC
